---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-025123"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T12:00:18.396426+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics enters $100M ATM equity offering with Jefferies; terminates prior Cantor agreement

## Summary
- Company entered Open Market Sale Agreement with Jefferies LLC to sell up to $100M of common stock.
- Jefferies will receive 3.0% commission on gross sales price per share; issuer has no obligation to sell.
- Prior ATM agreement with Cantor Fitzgerald terminated effective March 14, 2025; no shares sold under it.
- Offering will be made under new S-3 registration statement filed March 19, 2025.
- No material penalties incurred from termination of Cantor agreement.

## SEC filing metadata
- accession: 0001213900-25-025123
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/0001213900-25-025123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/ea0234885-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-025123
- JSON: https://secwatch.observer/filing/0001213900-25-025123.json
- Plain text: https://secwatch.observer/filing/0001213900-25-025123.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.